Mode
Text Size
Log in / Sign up

Narrative review on polysaccharide metabolites from kidney-tonifying TCM for osteoporosis

Narrative review on polysaccharide metabolites from kidney-tonifying TCM for osteoporosis
Photo by CDC / Unsplash
Key Takeaway
Consider that preclinical TCM metabolite data for osteoporosis lack human validation and clinical applicability.

This is a narrative review that synthesizes preclinical evidence on polysaccharide metabolites from kidney-tonifying traditional Chinese medicine for osteoporosis. The scope is limited to preclinical findings, as the authors do not report primary outcomes, sample sizes, or clinical trial data. The review argues that these metabolites may have potential based on mechanistic studies, but it provides no pooled effect sizes or quantitative synthesis.

The authors note that clinical translation remains limited because most findings await validation in human trials. They acknowledge that the evidence is early and incomplete, with no reported safety or tolerability data. The review does not describe a specific study population, intervention comparator, or adverse events.

Limitations include the lack of human data and the need for further validation. The authors do not report practice relevance, funding, or conflicts of interest. The synthesis is qualitative and does not support causal claims about efficacy in patients.

Clinicians should interpret these preclinical findings with caution, as they are not yet applicable to patient care. The review highlights a gap between mechanistic research and clinical practice for osteoporosis management with traditional Chinese medicine metabolites.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Osteoporosis, a prevalent systemic skeletal disorder, poses a significant health risk to the elderly population, arising from a multitude of factors that disrupt bone homeostasis. This delicate balance is primarily regulated by the dynamic interplay between osteoblasts and osteoclasts. When this equilibrium is perturbed, osteoporosis can ensue. Traditional Chinese Medicine (TCM) posits that the kidney, as the repository of vital essence, is instrumental in the production of bone marrow, which in turn confers skeletal strength. Consequently, TCM therapies that focus on kidney replenishment are frequently employed in the management of osteoporosis and other bone-related conditions. The polysaccharide metabolites of these TCM, which are designed to invigorate the kidney, exhibit a spectrum of pharmacological activities and engage multiple targets, such as Wnt and BMP-2/Smads signaling pathway activation and oxidative stress reduction. Notably, the protective and therapeutic roles of these polysaccharides in osteoporosis are mediated through distinct mechanisms and pathways. This review provides an overview of the application of the polysaccharide metabolites of kidney-tonifying TCM in the field of osteoporosis, with special emphasis on the mechanisms underlying the pharmacological effects of the various polysaccharide metabolites. It meticulously examines the precise molecular underpinnings and pathways through which these polysaccharides influence osteogenesis and osteoclastogenesis, with the aim of providing a robust foundation for future investigative endeavors and clinical applications of these polysaccharide metabolites in TCM kidney-tonifying therapies. This review summarizes preclinical evidence from animal and cell studies. However, clinical translation remains limited as most findings await validation in human trials. Moreover, this review aims to bolster the empirical evidence supporting the TCM principle that “the kidney governs the bones,” thereby enriching the understanding and practical application of this ancient medical wisdom in contemporary healthcare settings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.